Bioplastics research: Difference between revisions
No edit summary |
|||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Spoilore|Projects}} | |||
== Timeline== | |||
* {{:Timeline/minus/shellDARPA}} | |||
== Lab Notes == | == Lab Notes == | ||
Line 9: | Line 16: | ||
== See Also == | == See Also == | ||
* [[Dr. Barnhoff]] | * [[Dr. Barnhoff]] | ||
* [[Bionics research]] | |||
* {{wut|nidus}} | |||
[[Category:Projects]] | [[Category:Projects]] |
Latest revision as of 01:14, 23 September 2020
SPOILERS: Lore pages, by their nature, are spoilers. The story and game lore is meant to be experienced in-game; discovering lore via this wiki will likely detract from your enjoyment of the game. The content presented here may be inaccurate, out of context, out of date, and/or confusing. It is unofficial and non-canonical. Projects |
Timeline
- Big Picture 2018: First phase development of CBMs, using bioplastic technology derived from research conducted on mi-go. Aided by Melchior, research is extremely promising. Some government elements begin to notice that a few shell corporations have sprung up with access to DARPA-level technology. They are hastily silenced and/or brought into the fold.
Lab Notes
The bioplastics are working better than we could have anticipated. We're able to get them to interface with nerves, of course, but we've got models for versions that can serve as tissue lattices to grow blood vessels and muscle as well. Hypothetically we could probably use this stuff to make all kinds of replacement tissue, although that tech is decades away. In the meantime, making a digital-neural interface just got far easier than ever.
The mice with bioplastic modules are still susceptible to skin breakdown over the surgical sites, as with indwelling prosthetics. We haven't seen any increased sign of infection though. The immune system recognizes the bioplastic as 'self' with the right calibration, and once it grows into the body, the bioplastic doesn't serve as a nidus for bacteria.
We haven't completely solved the skin breakdown issue, which is going to mean prosthesis with bioplastics still has some disadvantages, but we've definitely improved it. On dermal-facing sides of bioplastic modules, we can use a slightly different bioplastic formula to encourage the dermis to grow right into the bioplastic and interface with it. If we can work out a way to further encourage subcutaneous fat and fibrous tissue, we might be able to get callous formation and healing of stress points, rather than ulceration and infection. In other words, we'd get the external prosthesis-facing surface to behave like feet in a shoe rather than knees on the floor. Even if this doesn't pan out, the ability of the skin to grow into the plastic means we can make smooth curved surfaces inside the amputation site, and matching smooth cups on the outside, for a clean distributed interface that should be miles ahead of existing technology.